Elixinol Historical Income Statement

EXL Stock

0.03 0 3.23%

Historical analysis of Elixinol Wellness income statement accounts such as Total Revenue of 14.2 M or Gross Profit of 5.1 M can show how well Elixinol Wellness Limited performed in making a profits. Evaluating Elixinol Wellness income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Elixinol Wellness's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Elixinol Wellness latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Elixinol Wellness is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elixinol Wellness Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Elixinol Income Statement Analysis

Elixinol Wellness Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Elixinol Wellness shareholders. The income statement also shows Elixinol investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Elixinol Wellness Income Statement Chart

At this time, Elixinol Wellness' Other Operating Expenses is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 5.6 M in 2025, whereas Total Revenue is likely to drop slightly above 14.2 M in 2025.

Selling General Administrative Total Revenue Other Operating Expenses Cost Of Revenue

Total Revenue

Total revenue comprises all receipts Elixinol Wellness generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Elixinol Wellness. It is also known as Elixinol Wellness overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Elixinol Wellness income statement and represents the costs associated with goods and services Elixinol Wellness provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Elixinol Wellness' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Elixinol Wellness current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elixinol Wellness Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Total Operating Expenses	6.7M	3.4M	8.8M	8.4M
Cost Of Revenue	10.3M	5.0M	9.6M	9.1M

Total Operating Expenses Cost Of Revenue

Elixinol Wellness income statement Correlations

	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Minority Interest	Tax Provision	Discontinued Operations	Depreciation And Amortization	Selling And Marketing Expenses	Ebitda	Net Interest Income	Interest Income	Reconciled Depreciation
Selling General Administrative		0.63	0.52	0.42	0.21	-0.15	-0.16	0.67	0.66	-0.23	-0.46	-0.29	-0.44	0.51	-0.34	0.22	0.28	0.45	-0.46	0.53	0.61	0.4
Total Revenue	0.63		0.94	0.17	0.72	0.31	0.36	0.96	0.99	0.25	-0.09	0.17	0.17	0.94	-0.09	0.08	0.03	0.11	-0.07	0.15	0.16	0.02
Gross Profit	0.52	0.94		-0.09	0.89	0.59	0.59	0.8	0.91	0.54	0.21	0.47	0.24	0.92	-0.02	0.32	-0.3	-0.13	0.2	0.28	0.15	-0.3
Other Operating Expenses	0.42	0.17	-0.09		-0.53	-0.66	-0.71	0.36	0.16	-0.75	-0.74	-0.74	-0.26	-0.13	-0.35	-0.64	0.88	0.99	-0.75	-0.22	0.18	0.68
Operating Income	0.21	0.72	0.89	-0.53		0.82	0.83	0.51	0.69	0.81	0.53	0.75	0.36	0.84	0.16	0.55	-0.66	-0.56	0.53	0.31	0.02	-0.58
Net Income From Continuing Ops	-0.15	0.31	0.59	-0.66	0.82		0.76	0.05	0.26	0.98	0.9	0.98	0.19	0.44	0.01	0.54	-0.89	-0.67	0.64	0.25	-0.03	-0.88
Ebit	-0.16	0.36	0.59	-0.71	0.83	0.76		0.15	0.33	0.84	0.68	0.79	0.66	0.54	0.62	0.54	-0.74	-0.78	0.89	0.01	-0.42	-0.62
Cost Of Revenue	0.67	0.96	0.8	0.36	0.51	0.05	0.15		0.97	-0.01	-0.33	-0.09	0.1	0.87	-0.14	-0.13	0.29	0.3	-0.28	0.02	0.14	0.28
Total Operating Expenses	0.66	0.99	0.91	0.16	0.69	0.26	0.33	0.97		0.21	-0.15	0.12	0.14	0.95	-0.1	0.09	0.06	0.11	-0.11	0.16	0.18	0.09
Income Before Tax	-0.23	0.25	0.54	-0.75	0.81	0.98	0.84	-0.01	0.21		0.93	0.99	0.3	0.41	0.18	0.57	-0.92	-0.76	0.76	0.18	-0.16	-0.85
Total Other Income Expense Net	-0.46	-0.09	0.21	-0.74	0.53	0.9	0.68	-0.33	-0.15	0.93		0.95	0.2	0.06	0.15	0.47	-0.9	-0.74	0.76	0.06	-0.24	-0.86
Net Income	-0.29	0.17	0.47	-0.74	0.75	0.98	0.79	-0.09	0.12	0.99	0.95		0.26	0.32	0.12	0.55	-0.92	-0.75	0.74	0.18	-0.14	-0.88
Income Tax Expense	-0.44	0.17	0.24	-0.26	0.36	0.19	0.66	0.1	0.14	0.3	0.2	0.26		0.24	0.8	-0.03	-0.14	-0.37	0.66	-0.45	-0.7	-0.23
Minority Interest	0.51	0.94	0.92	-0.13	0.84	0.44	0.54	0.87	0.95	0.41	0.06	0.32	0.24		0.02	0.23	-0.18	-0.19	0.1	0.18	0.09	-0.1
Tax Provision	-0.34	-0.09	-0.02	-0.35	0.16	0.01	0.62	-0.14	-0.1	0.18	0.15	0.12	0.8	0.02		0.13	-0.16	-0.46	0.74	-0.42	-0.77	-0.06
Discontinued Operations	0.22	0.08	0.32	-0.64	0.55	0.54	0.54	-0.13	0.09	0.57	0.47	0.55	-0.03	0.23	0.13		-0.74	-0.57	0.5	0.78	0.37	-0.47
Depreciation And Amortization	0.28	0.03	-0.3	0.88	-0.66	-0.89	-0.74	0.29	0.06	-0.92	-0.9	-0.92	-0.14	-0.18	-0.16	-0.74		0.86	-0.76	-0.37	0.02	0.88
Selling And Marketing Expenses	0.45	0.11	-0.13	0.99	-0.56	-0.67	-0.78	0.3	0.11	-0.76	-0.74	-0.75	-0.37	-0.19	-0.46	-0.57	0.86		-0.81	-0.09	0.32	0.66
Ebitda	-0.46	-0.07	0.2	-0.75	0.53	0.64	0.89	-0.28	-0.11	0.76	0.76	0.74	0.66	0.1	0.74	0.5	-0.76	-0.81		-0.1	-0.56	-0.66
Net Interest Income	0.53	0.15	0.28	-0.22	0.31	0.25	0.01	0.02	0.16	0.18	0.06	0.18	-0.45	0.18	-0.42	0.78	-0.37	-0.09	-0.1		0.86	-0.22
Interest Income	0.61	0.16	0.15	0.18	0.02	-0.03	-0.42	0.14	0.18	-0.16	-0.24	-0.14	-0.7	0.09	-0.77	0.37	0.02	0.32	-0.56	0.86		0.06
Reconciled Depreciation	0.4	0.02	-0.3	0.68	-0.58	-0.88	-0.62	0.28	0.09	-0.85	-0.86	-0.88	-0.23	-0.1	-0.06	-0.47	0.88	0.66	-0.66	-0.22	0.06

Click cells to compare fundamentals

Elixinol Wellness Account Relationship Matchups

Elixinol Wellness income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Expense	49K	92K	71K	101K	116.2K	92.7K
Selling General Administrative	8.6M	5.5M	4.4M	6.2M	2.6M	2.5M
Total Revenue	15.0M	9.3M	7.1M	8.3M	15.0M	14.2M
Gross Profit	(9.6M)	(6.3M)	(3.3M)	3.3M	5.4M	5.1M
Other Operating Expenses	40.3M	24.9M	17.1M	14.3M	18.4M	21.0M
Operating Income	(25.3M)	(15.6M)	(10.0M)	(6.0M)	(3.5M)	(3.3M)
Net Income From Continuing Ops	(104.5M)	(27.9M)	(10.6M)	(7.5M)	(6.8M)	(6.4M)
Ebit	(26.6M)	(17.0M)	(10.0M)	(7.4M)	(5.1M)	(4.8M)
Cost Of Revenue	24.6M	15.6M	10.3M	5.0M	9.6M	9.1M
Total Operating Expenses	15.7M	9.4M	6.7M	3.4M	8.8M	8.4M
Income Before Tax	(99.2M)	(17.1M)	(10.6M)	(7.5M)	(5.3M)	(5.0M)
Total Other Income Expense Net	(75.0M)	(1.5M)	(567K)	(1.5M)	(1.8M)	(1.9M)
Net Income Applicable To Common Shares	(82.9M)	(104.5M)	(17.0M)	(10.6M)	(9.5M)	(9.0M)
Net Income	(104.5M)	(17.0M)	(10.6M)	(7.5M)	(1.7M)	(1.8M)
Income Tax Expense	4.2M	(65K)	2K	3K	3.6M	5.6M
Tax Provision	4.2M	(65K)	2K	3K	3.5K	3.6K
Depreciation And Amortization	3.2M	1.5M	721K	597K	540K	998.5K
Selling And Marketing Expenses	7.2M	3.7M	2.3M	1.8M	2.4M	3.8M
Ebitda	(23.4M)	(15.5M)	(9.3M)	(6.8M)	(4.5M)	(4.7M)
Net Interest Income	51K	(63K)	(49K)	112K	100.8K	139.3K
Interest Income	100K	8K	22K	213K	191.7K	371.5K
Reconciled Depreciation	3.2M	2.3M	721K	597K	537.3K	510.4K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elixinol Stock Analysis

When running Elixinol Wellness' price analysis, check to measure Elixinol Wellness' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixinol Wellness is operating at the current time. Most of Elixinol Wellness' value examination focuses on studying past and present price action to predict the probability of Elixinol Wellness' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixinol Wellness' price. Additionally, you may evaluate how the addition of Elixinol Wellness to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC